Lifecare AS
OSE:LIFE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.6
55.8363
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Lifecare AS
Lifecare AS
Cash & Cash Equivalents
Lifecare AS
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecare AS
OSE:LIFE
|
Cash & Cash Equivalents
kr48.3m
|
CAGR 3-Years
62%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Medistim ASA
OSE:MEDI
|
Cash & Cash Equivalents
kr107.1m
|
CAGR 3-Years
26%
|
CAGR 5-Years
30%
|
CAGR 10-Years
15%
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Cash & Cash Equivalents
kr13.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
86%
|
CAGR 10-Years
N/A
|
|
Lifecare AS
Glance View
Lifecare AS engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
See Also
What is Lifecare AS's Cash & Cash Equivalents?
Cash & Cash Equivalents
48.3m
NOK
Based on the financial report for Dec 31, 2023, Lifecare AS's Cash & Cash Equivalents amounts to 48.3m NOK.
What is Lifecare AS's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
18%
Over the last year, the Cash & Cash Equivalents growth was 2%. The average annual Cash & Cash Equivalents growth rates for Lifecare AS have been 62% over the past three years , 18% over the past five years .
You don't have any saved screeners yet
